Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Tomasini P 

PROVIDER: S-EPMC5949420 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature